Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samar Padder

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentSamar Padder, Whitaker Cohn, Jesus J Campagna, et al.
Drugs in Context|April 14, 2025
Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008-2024) and pipeline phase III medicationsEmile Tadros, Shirley Keerthana, Samar Padder, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 21, 2025
Discovery of an APP-selective BACE1 inhibitor for Alzheimer's diseaseJesus Campagna, Barbara Jagodzinska, Dongwook Wi, et al.
Scientific Reports|April 24, 2025
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's diseaseJesus Campagna, Sujyoti Chandra, Bruce Teter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSamar Padder, Jesus J Campagna, Sujyoti Chandra, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentSamar Padder, Whitaker Cohn, Jesus J Campagna, et al.
Drugs in Context|April 14, 2025
Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008-2024) and pipeline phase III medicationsEmile Tadros, Shirley Keerthana, Samar Padder, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 21, 2025
Discovery of an APP-selective BACE1 inhibitor for Alzheimer's diseaseJesus Campagna, Barbara Jagodzinska, Dongwook Wi, et al.
Scientific Reports|April 24, 2025
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's diseaseJesus Campagna, Sujyoti Chandra, Bruce Teter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSamar Padder, Jesus J Campagna, Sujyoti Chandra, et al.
Pageof 1